Metastatic Liver Cancer Patient Registry Study
Part of Cancer, Digestive system clinical trials.
This study collects health information from patients with cancer that has spread to the liver. Researchers will track your medical history and outcomes to better understand how metastatic liver cancer develops and progresses.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Your cancer must have spread to the liver (confirmed by biopsy or imaging)
- You must be 18 years or older
- You must be able to understand and sign an informed consent form
- Your complete medical records and baseline health data must be available
- You cannot have primary liver cancer (cancer that started in the liver)
- You cannot currently be enrolled in other interventional clinical trials
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study is creating a database of people with liver cancer (including hepatocellular carcinoma and other types). It aims to collect health information and samples over time to better understand the disease and improve future care. If you join, you will be asked to provide blood and leftover tissue from surgery or biopsy, and to follow up with the research team.
This trial studies people who have liver metastases from cancers other than colorectal cancer and are undergoing surgery to remove them. It aims to gather data on outcomes after liver resection.
This study looks at how breast cancer that has spread to the liver responds to different treatments, including surgery and medicines. The goal is to learn which approach works best for patients with this condition.
This study observes people with stomach cancer that has spread to the liver. It looks at how the disease progresses and how patients respond to their usual treatments over time.
This study tests immune-based treatments (called PDO, PDO-TIL, and PDOTS) for people with liver cancer that has spread or can’t be removed by surgery. It aims to see how well these treatments work and how safely they can be given.
This trial studies patients with liver cancer, including both the common type (hepatocellular carcinoma) and other types. It aims to understand the cancer better by collecting blood samples and medical information.
Hear when a new Liver Metastases trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.